Avery Dennison (AVY) Q1 2026 Earnings Transcript

Avery Dennison reported Q1 adjusted EPS of $2.47, up 7% year over year, on 7% reported sales growth and strong Materials Group performance, while Solutions Group margins fell 80 bps to 16.4%. The company guided Q2 adjusted EPS to $2.43-$2.53 and sales growth of 2%-4%, but flagged high-single-digit sequential raw material inflation and a $0.05 Q1 prebuy tailwind that reverses in Q2. Management also raised 2026 restructuring savings to more than $55 million and reaffirmed $260 million of fixed and IT capex, while continuing buybacks and dividends.

Analysis

AVY is quietly turning inflation from a margin risk into a competitive moat. In a tightening raw-material tape, the winners are the firms with the best procurement, the most credible price discipline, and enough service reliability to prevent customer defection; smaller label converters should feel the squeeze first, especially where mix is more commoditized and working capital is less efficient. The near-term spread dynamic is favorable for AVY because pricing actions can follow cost with only a short lag, while the broader sector likely faces a temporary inventory whipsaw as customers prebuy and then destock.

The more important second-order effect is that the company is using the inflation window to accelerate share gains in core labels while forcing a reset in weaker categories. That matters because volume quality, not just headline growth, will determine whether the Materials margin expansion is durable into the back half; if high-value platforms reaccelerate as guided, the business can absorb cost inflation without surrendering earnings power. The risk is that the expected unwind of March prebuys and higher sequential inflation hit in the same quarter, creating a visible Q2 air pocket that may invite a knee-jerk derating even if the full-year setup is intact.

The Intelligent Labels investment is strategically more interesting than the quarterly print. AVY is effectively buying a second growth vector tied to food and condition monitoring, which expands the addressable market and could reduce dependence on logistics, where last year’s share gains create a tougher comp and more volatile normalize-down risk. The contrarian point: consensus may be underestimating how quickly this platform can re-rate the stock if food pilots scale in 2H, because the market tends to value AVY on cyclical packaging earnings and underappreciates optionality in sensing and track-and-trace.

For now, the setup looks like a quality compounder with a temporary Q2 volatility window rather than a broken demand story. The key watch items are whether pricing fully offsets the inflation spike by late Q2/early Q3, and whether IL can turn pilot activity into visible revenue inflection before year-end. If either slips, the stock will likely de-rate on 'margin pressure' headlines; if both hold, AVY has room to rerate on 2H earnings revisions and stronger FCF conversion.

Key Decisions for Investors

• Long AVY on any Q2-related weakness over the next 2-6 weeks; use the expected prebuy unwind and margin noise as entry, targeting a 3-6 month move higher into 2H pricing and IL ramp.
• Pair trade: long AVY / short a more commoditized packaging or label-converter peer over the next quarter; thesis is AVY’s superior pricing power and procurement scale will protect margins better in high-single-digit input inflation.
• Buy AVY Jan-2027 calls or call spreads to express the Intelligent Labels optionality; this is a 6-18 month catalyst trade where food rollout and condition-monitoring adoption can drive multiple expansion.
• Avoid chasing into the print; wait for the market to price in the temporary Q2 EPS swing, then add if the stock sells off on destocking fears without evidence of order deterioration.
• If AVY rallies hard on the call, consider a covered-call overlay for the next 30-45 days to monetize expected near-term volatility while keeping core exposure to the 2H earnings reset.